# A Study of MK-0616 in Healthy Adult Participants (MK-0616-009)

> **NCT06592339** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 24 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** MK-0616

## Key facts

- **NCT ID:** NCT06592339
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-25
- **Primary completion:** 2022-12-29
- **Final completion:** 2022-12-29
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06592339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06592339, "A Study of MK-0616 in Healthy Adult Participants (MK-0616-009)". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT06592339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*